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SUMMARY 
Approximately 25% of infants with birth weights less than 1800 g or 
infants of about 34 weeks gestational a.ge have an apneic episode. This, and 
the known high incidence of apneas in infants who subsequently are victims 
of sudden infant death syndrome, has led to aggressive attempts at early 
identification of newborns with abnormal cardio-respiratory patterns. We 
have found the pneumocardiogram to be effective in detecting cardio-res- 
piratory abnormality in the newborn, and a very useful tool in the assess- 
ment of the effectiveness of pharmacologic therapy of neonatal apnea. In- 
fants who are discharged on a home apnea monitor should be managed, 
utilizing a coordinated multidisciplinary team approach, that includes 24 h 
availability of a physician, technician, community health nurse, social wor- 
ker and, when possible, a member of a parent support group. This paper 
presents a review of neonatal apnea and our institutional approach to its 
evaluation and management. 
INTRODUCTION 
The majority of low birth weight infants have apneic spells (Alden, 
Mendelkorn, Woodrum, Wennberg, Parks and Hodson, 1972). Approximately 
25% of infants with birth weight less than 1800 g or 34 weeks gestation have 
apneic episodes (Daily, Klaus and Meyer, 1969). Aside from apnea, other 
forms of cardio-respiratory patterns have been implicated as causes of recur- 
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rent or chronic hypoxemia in the newborn infant (Westgate, 1982). For these 
reasons and because available epidemiologic data show a high incidence of 
apnea in infants (Steinschneider, 1972; Steinschneider, Weinstein and 
Diamond, 1982) who subsequently were victims of SIDS (Sudden Infant 
Death Syndrome), in our institution we are aggressively attempting the early 
identification of newborns with abnormal cardio-respiratory waveforms 
(Banagale, 1982a). 
POPULATION AT RISK AND DIAGNOSTIC WORK-UP 
Certain characteristics of premature infants, such as neurological im- 
maturity, immature chemical responses to* hypoxia and a propensity to 
develop intracranial hemorrhage, have predisposed them to develop ab- 
normal cardio-respiratory patterns and SIDS (Stein and Shannon, 1975; 
Kattwinkel, 1977; Kelly and Shannon, 1982; Rigatto, 1982; Sells, Neff, 
Bennett and Robinson, 1983). The population of infants at risk for SIDS 
however is not limited to the preterm infant and includes term newborns as 
well. This high risk population as a whole comprises a heterogenous group 
with numerous other factors (Valdes-Dapena, 1980) associated with the 
pathophysiology of SIDS. 
We routinely perform pneumocardiograms (Banagale, li821 on the follow- 
ing groups who are at risk for SIDS: (a) those with birth weight less than 
1800 g or with gestational age less than 34 weeks; (b) those with history of 
perinatal and/or neonatal asphyxia; (cl siblings of SIDS infants; (d) infants of 
mothers with narcotic addiction; and (e) those observed to have apnea, 
bradycardia, and other abnormal breathing patterns. Appropriate diagnostic 
TABLE I 
DEMONSTRABLE CAUSES OF ABNORMAL NEONATAL CARDIO-RESPIRATORY PAT- 
TERNS AND ELEMENTS OF DIAGNOSTIC WORK-UP 
1. Infection (sepsis, pneumonia and meningitis) 
a. CBC and differential count 
b. cultures (blood, cerebrospinal fluid, and urine) 
c. chest X-ray 
d. blood gases 
2. Glucose and electrolyte imbalance 
a. blocd sugar 
b. electrolytes including calcium and magnesium 
3. Cardiac, gastrv-esophageal, central nervous system, and upper airway anomaly 
a. EKG and/or echocardiogram 
b. barium esophagram, esophageal manometric and esophageal pH determinations 
c. cranial ultrasound and/or EEG 
d. laryngoscopy, soft-tissue radiography of the neck and bronchoscopy 
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work-up, as shown in Table I, guided by the pertinent history and physical 
examination findings, should be undertaken to rule out the commonly treat- 
able causes of car&o-respiratory disturbances in infants. Careful search for 
the presence of infection, glucose, electrolyte, calcium and magnesium im- 
balance, severe anemia and polycythemia or hyperviscosity should be done. 
Chest radiograph, electrocardiogram and echo-cardiogram are useful m the 
evaluation of a possible cardiac anomaly. When gastro-esophageal reflux is 
suspected (Herbst, Minton and Book, 1979), barium esophagram, esophageal 
manometric study and esophageal pH measurements are helpful procedures 
to confirm the diagnosis. In premature newborns, cranial ultrasounds should 
be performed to rule out intracranial hemorrhage. Some infants with seizure 
activity may present with apnea and an electroencephalogram is a useful 
diagnostic tool. A careful search for the presence of an upper airway obstruc- 
tion should be accomplished. Laryngoscopy, soft tissue neck radiograph and 
bronchoscopy should be done when indicated. When no demonstrable or 
treatable cause can be identified to explain the infant’s observed apnea, 
bradycardia or “cyanotic spells”, we perform a pneumocardiogram. 
PNEUMOCAFLDIOGRAM 
Pneumocardiogram (PCG), also known as pneumogram, nocturnal cardio- 
respirography or cardio-pneumogram, is still considered by some in- 
vestigators as a controversial tool in the assessment of infantile apnea 
(Brooks, 1982). This is due to some yet unresolved limitations of PCG which 
include: (1) the absence of a generally accepted definition or terminology of 
what constitutes abnormal cardio-respiratory patterns, other than the 
obvious prolonged apnea (American Academy of Pediatrics Task Force on 
Prolonged Apnea, 1978) and profound bradycardia; (2) some investigators 
have shown that some infants at risk for SIDS show no abnormality in PCG 
(Southall, Richards, Rhoden, Alexander, Shinebourne, Arrowsmith, Cree, 
Fleming, Goncalves and Orme, 1982) and that some infants with obstructive 
apnea were detected only with the use of an acoustic monitor (Werthammer, 
Krasner, DiBenedetto and Stark, 1983). However, in the absence of a 
demonstrable or treatable cause as we have previously delineated, we have 
found the PCG to be an effective tool in detecting variations in newborn 
cardio-respiratory waveforms. Such variations or abnormalities may in the 
future be established as a major cause of chronic or recurrent hypoxemia in 
newborn infants. We have also found that PCG is more accurate than the 
combined bed-side observation and conventional apnea devices in detecting 
significant episodes of abnormal cardio-respiratory patterns (Beaumont and 
Roloff, 1982). 
PCG is simple to perform and provides an objective quantification of 
respiratory rate, rhythm, relative amplitude of inspiration, frequency and 
duration of apnea and/or bradycardia (Banagale, 1982a) PCG has also been 
very useful in the assessment of the effectiveness of pharmacologic (theo- 
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phylline or caffeine) therapy of neonatal apnea (Banagale, 1982b; Banagale, 
1983). 
PCG is not a polysomnogram (multi-channel recording of awake and 
asleep states), rather, it is a two-channel recording that measures elec- 
trocardiographic activity (ECG) and respiratory wave forms by an impedance 
technique, performed at night when long episodes of deep sleep are likely to 
occur. It requires on the average a 12-h recording onto slow speed magnetic 
tape. We record PCG with a Healthdyne INFA-DATABmonitor recorder 
(Healthdyne, Marietta, GA). The recorded tape is reviewed on a specialized 
computer based playback system using the PMD-12 Respiration Beplay- 
Display System@ (Oxford Medical System Limited, Abingdon, Oxon). The 
system permits visual display and examination of the pneumocardiographic 
patterns on an oscilloscopic display. A hard copy of the trend recording 
(360 s/page) which shows heart rate and respiratory waveform is obtained 
and apnea, bradycardia, and other abnormal breathing patterns are 
identified, measured, quantitated and analyzed page-by-page. Any data of 
significant abnormality can be viewed and/or printed out at slower speed 
(real time = 6 s/page) which shows ECG and respiratory waveform. Figure 1 
shows a 312-s segment of a 720-min trend recording. It shows the relative 
regularity of the respiratory rate (35/min) and the heart rate (14O/min). 
Based on our own experience, that of other investigators (Stein, 1979; 
Kelly, 1980; Stark, 1982), and from the wide experience of Dr. Eugene 
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Fig. 1. A 312-s segment of a 720-min trend recording. The respiratory rate is 35/min and the 
baseline heart rate is 14O/min. 
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TABLE II 
ABNORMAL PNEUMOCARDIOGRAPHIC FINDINGS 
1. Apnea greater than 15 s 
2. Periodic breathing” of more than 5% of the total trend recording 
3. Bradycardia (recovery time of more than 10 s) 
a. less than 80/min in infants less than 1 month of age 
b. less than 7O/min in infants l-3 months of age 
c. less than 6O/min in infants 3-6 months of age 
4. Disorganized breathing consisting of irregular respirations with short apneas of less than 15 s 
accompanied by bradycardia. 
“Periodic breathing-three or more respiratory pauses of greater than 3 s, with less than 20 s of 
normal respiration separating the pauses. 
gan [per-s. commun.], we consider the presence of any of the criteria listed in 
Table II an “abnormal” pneumocardiogram. Figure 2 shows an example of a 
periodic breathing pattern. It represents a 427-s period periodic breathing on 
a 558-s segment of a total 720-min trend recording. Figure 3 shows an 
example of a “short apnea” (apnea less than 15 s). It represents a 12.3-s 
apneic spell without bradycardia on a 320-s segment of a total 720-min trend 
recording. Figure 4 shows two “long apneas” (apnea more than 15s). These 
are a 19.2-s segment of apnea and a 22.3-s apnea with bradycardia of a total 
720-min trend recording. The pneumocardiogram is sensitive to the motion of 
the electrodes or wires, which produce changes in the DC offset, resulting in 
artifact patterns (Stark, 1982) as shown in Fig. 5. It represents a 324s 
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Fig. 4. A 317-8 segment of a 720-min trend recording showing apnea of 19.2 B duration without 
bradycardia. The 22.3-s apnea is accompanied by bradycardia of 55/min lasting 24 s. 
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BPM-RR interval Trend 
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j-j 12sec 
Fig. 5. A 324s segment of a 720-min trend recording with artifact patterns and interruptions of 
heart rate tracing. 
artifact patterns with interruptions in otherwise regular heart rate recor- 
ding. 
MANAGEMENT 
Specific treatment is instituted depending on the findings in the previously 
delineated diagnostic work-up. Infants whose abnormal cardio-respiratory 
pattern does not improve with specific therapy and those infants with 
abnormal car&o-respiratory patterns without demonstrable cause are started 
on oral theophylline liquid (theophylline USP, anhydrous, in a non-alcoholic 
solution), using a loading dose of 6 mg/kg body weight. The maintenance oral 
dose is 2 mg/kg body weight/dose administered every 12 h. The oral main- 
tenance dose is adjusted to obtain a serum theophylline level of 8-12 pg/ml. 
We determine serum theophylline level by a micro-scale measurement utiliz- 
ing high-pressure liquid chromatography (Orcutt, Kozak, Gillman and 
Cummins, 1977). It is essential that a concomitant serum caffeine measure- 
ment be performed because of significant biotransformation of theophylline 
to caffeine in newborns receiving theophylline (Bada, Kanna, Somani and 
Tin, 1979; Bory, Baltassault, Porthault, Bethenod, Frederich and Aranda, 
1979; Aranda, Grondin and Sasyniuk, 1981; Banagale, 1982a,b). This bio- 
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transformation of theophylline to caffeine in newborns includes N-methyl- 
ation at the N7 position, whereas the known metabolic pathway of theophyl- 
line in adults involves oxidative reactions such as N-demethylation (N,, N3) 
and C-8 oxidation. Methylated serum caffeine has potentiating effect and 
levels as low as 3-4 @g/ml have been shown to regularize abnormal respira- 
tory patterns. The pharmacologic effect of methylated serum caffeine is 
either due to the therapeutic effect of caffeine alone or due to its additive 
effect to theophylline leading to a higher total methylxanthine load. 
A. Infants discharged without home apnea monitor 
An infant whose abnormal breathing pattern has responded to ad- 
ministration of theophylline as evidenced by a normal repeat PCG at 3-7 
days after the initiation of therapy is sent home on medication without a 
home apnea monitor. These infants are followed closely in our High Risk 
Developmental Follow-Up Clinic and also in the primary care physician’s 
office. Periodic determination of their serum theophylline and caffeine levels 
is performed. Medication is adjusted to maintain therapeutic serum theo- 
phylline levels and the infants are monitored for evidence of drug toxicity 
(Steinschneider, 1972). The duration of treatment with theophylline has been 
variable but these infants usually have a normal PCG when theophylline is 
discontinued at about 44 weeks corrected gestational age (conceptional age). 
During the process of weaning the infant off medication, he or she may 
temporarily be placed on a home apnea monitor and the monitor is dis- 
continued when the follow-up PCG is normal without medication. Infants who 
fail the attempt to discontinue the medication, as evidenced by an abnormal 
follow-up PCG, are restarted on medication. These infants, as previously 
indicated, are taken off the apnea monitor when the repeat PCG is normal with 
medication. Some infants require such trials of weaning 2-4 times before the 
appropriate response is attained. 
It should also be emphasized that premature infants have a remarkably 
slow elimination of theophylline and caffeine. Theophylline can be detected 
in the plasma up to 3 days after cessation of theophylline therapy and 
caffeine can still be detected up to 9 days after treatment (Bory et al., 1979). 
Therefore, the potentiating effect of methylated caffeine should be considered 
not only at the initial phase of theophylline therapy, but also during and at 
the termination of treatment (Banagale, 198213; Banagale, 1983). 
B. Infants discharged on home apnea monitor 
There are two groups of infants who are discharged on home apnea 
monitor: first, those infants whose PCG is abnormal despite adequate serum 
theophylline and/or caffeine levels; second, surviving twins of SIDS victims 
and the subsequent siblings of victims of SIDS proven at autopsy. 
Infants belonging to the first group predominantly consist of premature 
infants who, other than their abnormality of cardio-respiratory patterns, are 
growing, but have not yet met our criteria for discharge. In addition to the 
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previously mentioned diagnostic work-up, they undergo further evaluation 
for any other possible unrecognized and treatable cause. When indicated, 
metabolic and amino acid screen is performed. Polysomnography (Hoppen- 
brouwers, Hodgman, Harper, Hofmann, Sterman and McGinty, 1977; Kahn, 
Bloom, Waterschoot, Engelman and Smets, 1982) or performance of brain 
stem evoked potential may at times be necessary (Westgate, 1982). A few 
infants have been treated with phenobarbital because of the suggestion of 
seizure activity on EEG (Watanabe, Hara, Hakamada, Negoro, Sugiura, 
Matsumoto and Maehara, 1982; Watanabe, Hara, Miyazaki, Hakamada and 
Kuroyanagi, 1982). 
Infants belonging to the second group consist of those who undergo 
diagnostic work-up based on the history of a sibling dying of SIDS (Kelly, 
Twanmoh and Shannon, 1982). Because of the high statistical risk factor of 
this group of infants, coupled with the extreme parental and/or physician 
anxiety, they are commonly sent home on an apnea monitor even when no 
treatable cause is found and, in some instances, irrespective of the result of 
PCG. 
The parents of this group of infants undergo an extensive hospital dis- 
charge planning which is provided by a coordinated multi-disciplinary team. 
Table III shows an assessment of the family unit including the parents’ 
understanding of the purposes of home apnea monitoring as well as the home 
care cost. Evaluation of the extent of insurance coverage for the cost of the 
equipment, accessories and needed services is undertaken. In Michigan, the 
Division of Services to Crippled Children (DSCC) has provided financial 
assistance for medical and nursing care of home apnea monitored infants 
provided the rigid but appropriate medical criteria for placement of the home 
apnea monitor are met. The coping ability of the parents, including the other 
members of the family, is also taken into consideration. 
Table IV outlines the in-hospital educational process given to the parents 
and extended family members (other caretakers). They are taught the ap- 
propriate performance of cardiopulmonary resuscitation. A technical per- 
sonnel or a monitor dealer representative explains the proper use of the 
monitor including needed supplies and services. Plans on how to handle an 
emergency situation are also discussed. This includes local emergency ser- 
vices, such as the ambulance company or emergency medical services. The 
power company is notified to provide priority service to the family in case of 
TABLE III 
FAMILY ASSESSMENT 
1. Parents’ acceptance and ability to understand advantages and disadvantages of home apnea 
monitoring 
2. Coping ability and family support system 
3. Appropriateness of home environment 




1. Proper use of apnea monitor 
2. Proper performance of cardiopulmonary resuscitation 
3. Monitor installation and related services 
4. Proper maintenance of record or event data sheet 
5. Emergency support plans, especially physician and emergency room accessibility 
power failure. The parents and other caretakers are also instructed as to the 
proper maintenance of the record or event data sheet, as well as immediate 
access to the emergency room. 
As shown in Table V, appropriate referrals to the related community 
agencies are also accomplished to ensure proper follow-up of the infant and 
the provision of adequate medical and psychosocial support to the parents 
and their family. The coordinated multi-disciplinary team approach includes 
the 24-h availability of a physician, technician, community health nurse, 
social worker and, when possible, a member of a parent support group. 
There is always a concerted effort to minimize the stress produced by 24-h 
home apnea monitoring (Black, Hersher, Steinschneider, 1978; Cain, Kelly 
and Shannon, 1980). 
The infant is followed closely in the primary care physician’s office and in 
the High Risk Developmental Follow-Up Clinic. Accurate therapeutic drug(s) 
monitoring is performed on infants who are discharged on theophylline 
and/or phenobarbital. 
At present, our criteria in considering an infant ready for discontinuation 
of the home apnea monitoring consist of: (1) the infant has had no apnea, 
bradycardia or “cyanotic spells” for at least 2 months; and (2) those infants 
who have had previously abnormal PCG should have a normal follow-up 
PCG, preferably two normal PCGs, 1 month apart. During this period, the 
infant’s cardio-respiratory response to upper respiratory tract infection 
TABLE V 
COMMUNITY REFERRAL AND FOLLOW-UP 
1. Home health care, or Visiting Nurse Association 
2. Social Services Department 
3. Financial aid 
a. Division of Services to Crippled Children (DSCC) 
b. March of Dimes, American Red Cross, National SIDS Foundation, or other available 
resources in the community 
4. Primary care physician 
5. High Risk Developmental Follow-Up Clinic 
6. Parent Support Group 
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and/or DPT immunization is taken into consideration. Siblings of SIDS 
victims (even those with normal PCG) are kept on monitor for 6 months. The 
process and timing of the discontinuation of home apnea monitor is not 
always consistent because of the above mentioned factors along with the 
differences in the degree of parental readiness and acceptance of disconnec- 
ting the infant from the monitor. The majority of these infants are success- 
fully discontinued from theophylline therapy and home apnea monitor in 
about 6 months. While the majority (91%) of SIDS deaths occur in the first 6 
months of life, the termination of home apnea monitoring and/or theophyl- 
line therapy is not a signal to discontinue meticulous follow-up care. These 
infants continue to be followed closely in the primary care physician’s office 
and in the High Risk Developmental Follow-Up Care Clinic. 
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